Expert opinions · patient guide

Breast Cancer in China: Reviewing Biopsy and Receptor Reports

If you are considering breast cancer care in China, the first practical step is to assemble a complete, legible pathology file: the original biopsy report, receptor results for ER, PR and HER2, and any prior systemic therapy records. A Chinese hospital team needs these to understand your tumour biology before discussing surgery, reconstruction or further treatment. An initial enquiry is free and does not require buying a proxy consultation.

Go to the practical guidance ↓
Editorial illustration: Breast Cancer in China: Reviewing Biopsy and Receptor Reports
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

What a Chinese breast team needs from your biopsy file

A breast cancer diagnosis is not one document. The core file usually contains the original biopsy or surgical pathology report, the receptor status results, imaging reports that describe the extent of disease, and a summary of any treatment already received. For an overseas patient, the practical problem is rarely that no records exist. It is that the records are scattered across a local hospital, a private laboratory and an oncology clinic, and the receiving team cannot reconstruct the case from fragments.

The biopsy report itself should identify the specimen type, the histological diagnosis and, where performed, the grade. If the biopsy was done at one hospital and the receptor testing at another, both reports matter. A Chinese specialist reviewing the case will want to see the actual report text, not a patient-written summary. If the report is in a language other than English or Chinese, a certified translation may be requested; ask the receiving hospital what it accepts before paying for translation.

Receptor status is central because it shapes which treatments are considered. Oestrogen receptor, progesterone receptor and HER2 results are typically reported together. If HER2 is equivocal, the report may mention reflex testing such as in situ hybridisation. Ask the pathology department whether that reflex test was performed and whether the result is included in the report you hold. Do not assume a negative HER2 result from a biopsy is the final word if the treating team has questions about the specimen.

Receptor results: what the numbers and categories mean for your questions

Receptor reports use categories and percentages that can look technical. Oestrogen and progesterone receptor results are often given as a percentage of positive cells plus an intensity score. HER2 is usually reported as negative, equivocal or positive, sometimes with a numeric score. These categories are not interchangeable, and a Chinese team will read the original report rather than a paraphrase.

The practical question for you is not to interpret the result yourself. It is to check that the report you are sending is the complete version, including any addendum or supplementary report. Some laboratories issue an initial report and then a revised or additional report after further staining. If you only send the first page, the receiving clinician may form an incomplete picture.

If you have had a previous breast cancer and a new biopsy, both the old and new receptor results are relevant. A change in receptor status between the original diagnosis and a later biopsy can affect how the current disease is approached. Ask your current pathology provider whether the older blocks or slides are available, because a Chinese hospital may request them for its own review rather than relying on a photocopy.

Prior systemic therapy: why the treatment history changes the surgical discussion

If you have already received chemotherapy, endocrine therapy, HER2-directed therapy or another systemic treatment, that history belongs in the file. It is not background colour. It tells the receiving team what has already been tried, how the tumour responded, and whether the current imaging reflects the disease before or after that treatment.

A common gap is the absence of treatment summaries. Infusion records, drug names, cycle dates and response assessments may sit in a different system from the pathology report. Ask your treating centre for a short clinical summary that lists the regimens used, the dates, and the reason each was stopped or changed. If a treatment was stopped early because of side effects, that detail matters as much as the fact that it was given.

Do not stop or change any ongoing systemic therapy in order to travel or to prepare an enquiry. If you are currently on treatment, the timing of any overseas consultation is a clinical decision for your current team. A records review can proceed in parallel with ongoing care, but it does not replace it.

Surgical extent and reconstruction: separate decisions, separate questions

Breast-conserving surgery and mastectomy remove different amounts of breast tissue, and the choice between them depends on tumour size, location, breast size and the patient's own priorities. Reconstruction after mastectomy is a separate discussion with its own timing, techniques and risks. A pathology file alone does not answer which operation is suitable for you.

When you approach a Chinese hospital, be clear about what you are asking. Are you seeking a review of the pathology and receptor results before deciding on surgery? Are you asking whether breast-conserving surgery is feasible, or whether mastectomy with or without reconstruction is the more appropriate route? These are different questions, and the records needed to answer them overlap but are not identical.

Reconstruction is not automatically part of a cancer operation. It may be discussed at the same time as the cancer surgery or planned as a later procedure, depending on the clinical situation and the team's assessment. Ask the receiving hospital how it structures that discussion and what additional imaging or assessment it requires. Do not assume that a particular reconstruction technique is available or suitable without the treating surgeon confirming it.

How to organise the file so a Chinese hospital can actually use it

A file that is complete but chaotic still slows the review. Organise the documents in a logical order: pathology reports first, then receptor results, then imaging, then treatment summaries, then any current medication list. Label each document with its date and the hospital or laboratory that issued it. If a report has multiple pages, keep them together.

Digital copies are usually easier to share than photographs of paper. Scan or photograph each page flat, in good light, with the whole page visible. Do not crop out the header, the laboratory name or the pathologist's signature. If a report is double-sided, include both sides. If you have a patient portal, download the PDF rather than taking a screenshot.

Before sending anything, decide what you are asking the Chinese team to do. A pathology review, a surgical opinion and a reconstruction discussion are different requests. State your main question in one or two sentences when you make contact. That helps the receiving team route your file to the right specialist rather than treating it as a general enquiry.

  • Pathology report: original biopsy and any later surgical specimen report, including addenda.
  • Receptor results: ER, PR and HER2 reports, including reflex testing if performed.
  • Imaging: mammogram, ultrasound, MRI or other staging reports with dates.
  • Treatment history: regimens, dates, response and reason for any change or stop.
  • Current status: medication list, recent assessment and your main question.

Related treatment reference

What to confirm with the hospital before you travel

Chinese hospitals differ in how they handle overseas pathology. Some will review your existing slides and reports; others may ask for blocks or slides to be sent, or may repeat selected tests. Ask the specific hospital what it requires in your case, rather than assuming a standard process. If a repeat test is requested, ask who performs it, where, and how the result will be shared with you.

Language and communication arrangements also need confirming. Ask whether the department can review English-language reports directly, whether an interpreter is needed for the consultation, and how the opinion will be documented. If you are sending records ahead, ask for written confirmation of what was received and what remains outstanding.

Cost is a separate question. Hospital charges for consultation, pathology review, imaging and any procedure are set by the hospital, not by a coordination service. Ask the hospital what its written estimate includes and what is not yet decided. If you use a coordination service, its fees are separate from hospital medical fees and are not credited, deducted or offset against later hospital charges.

An initial enquiry with ChinaSpecialistCare is free. It checks whether your records are sufficient to identify the relevant next step and what information is missing. It is not a diagnosis, and it does not confirm hospital acceptance or treatment availability. A proxy consultation, where a doctor takes your records to a hospital specialist while you remain at home, is optional and not a prerequisite for every appointment.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. NHS: Treatment for breast cancer

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.